{"doi":"10.3390/cancers8020019","title":"Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go","abstract":"<jats:p>Cancers are heterogeneous tissues comprised of multiple components, including tumor cells and microenvironment cells. The tumor microenvironment has a critical role in tumor progression. The tumor microenvironment is comprised of various cell types, including fibroblasts, macrophages and immune cells, as well as extracellular matrix and various cytokines and growth factors. Fibroblasts are the predominant cell type in the tumor microenvironment. However, neither the derivation of tissue-specific cancer-associated fibroblasts nor markers of tissue-specific cancer-associated fibroblasts are well defined. Despite these uncertainties it is increasingly apparent that cancer-associated fibroblasts have a crucial role in tumor progression. In breast cancer, there is evolving evidence showing that breast cancer-associated fibroblasts are actively involved in breast cancer initiation, proliferation, invasion and metastasis. Breast cancer-associated fibroblasts also play a critical role in metabolic reprogramming of the tumor microenvironment and therapy resistance. This review summarizes the current understanding of breast cancer-associated fibroblasts.</jats:p>","journal":"Cancers","year":2016,"id":601359,"datarank":0.7846662925281881,"base_score":5.231108616854587,"endowment":5.231108616854587,"self_citation_contribution":0.7846662925281881,"citation_network_contribution":0.0,"self_endowment_contribution":0.7846662925281881,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":186,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1541962,"name":"Sun Oh","orcid":null,"position":1,"is_corresponding":false},{"id":600812,"name":"Rachel J. Buchsbaum","orcid":"0000-0003-2502-9240","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go","abstract":"<jats:p>Cancers are heterogeneous tissues comprised of multiple components, including tumor cells and microenvironment cells. The tumor microenvironment has a critical role in tumor progression. The tumor microenvironment is comprised of various cell types, including fibroblasts, macrophages and immune cells, as well as extracellular matrix and various cytokines and growth factors. Fibroblasts are the predominant cell type in the tumor microenvironment. However, neither the derivation of tissue-specific cancer-associated fibroblasts nor markers of tissue-specific cancer-associated fibroblasts are well defined. Despite these uncertainties it is increasingly apparent that cancer-associated fibroblasts have a crucial role in tumor progression. In breast cancer, there is evolving evidence showing that breast cancer-associated fibroblasts are actively involved in breast cancer initiation, proliferation, invasion and metastasis. Breast cancer-associated fibroblasts also play a critical role in metabolic reprogramming of the tumor microenvironment and therapy resistance. This review summarizes the current understanding of breast cancer-associated fibroblasts.</jats:p>","is_dataset_classified":null,"base_score":5.231108616854587,"endowment":5.231108616854587,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"26828520","pmcid":"PMC4773742","openalex_id":"https://openalex.org/W2256616461","authors":[],"funders":[{"funder_name":"National Institutes of Health","grant_id":"T32 CA009429","title":null},{"funder_name":"National Institutes of Health","grant_id":"2T32CA009429-16","title":"RESEARCH TRAINING IN ONCOLOGY"}],"total_grants":2,"fwci":9.2163,"citation_percentile":0.98734056,"influential_citations":0,"citation_trend":[{"year":2014,"count":1},{"year":2016,"count":7},{"year":2017,"count":23},{"year":2018,"count":20},{"year":2019,"count":14},{"year":2020,"count":26},{"year":2021,"count":20},{"year":2022,"count":12},{"year":2023,"count":27},{"year":2024,"count":23},{"year":2025,"count":7},{"year":2026,"count":6}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/2072-6694/8/2/19/pdf?version=1453883499","host_type":"journal"},{"url":"https://www.mdpi.com/2072-6694/8/2/19/pdf?version=1453883499","host_type":"publisher"},{"url":"https://www.mdpi.com/2072-6694/8/2/19/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/cancers8020019","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/26828520","host_type":"repository"},{"url":"https://doaj.org/article/3469017cdb2943108c71eb0edb93ba54","host_type":"repository"},{"url":"https://dx.doi.org/10.3390/cancers8020019","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4773742","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC4773742","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC4773742?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.3390/cancers8020019","host_type":""}],"fields_of_study":["Cancer Cells and Metastasis","Metabolism, Diabetes, and Cancer","Cancer, Hypoxia, and Metabolism","03 medical and health sciences","0302 clinical medicine"],"mesh_terms":[],"keywords":["Cancer-Associated Fibroblasts","Tumor microenvironment","Cancer research","Breast cancer","Cancer","Extracellular matrix","Tumor progression","Cancer cell","Metastasis","Reprogramming","Biology","Medicine","Pathology","Cell","Internal medicine","Cell biology","Tumor cells","Review"],"sdg_mappings":[{"sdg_number":2,"sdg_label":"2. Zero hunger"},{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T16:03:59.492041Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}